In India schools are open, kids are back in the schools but they are not vaccinated. The Drug Controller General of India (DCGI) is yet to approve the Covaxin rule out for children.

India: Covaxin yet to get DCGI nod for kids

While hearing a plea based case on Friday, a&nbsp;division bench of Chief Justice D N Patel and Justice Jyoti Singh observed, “It would be a disaster if vaccines are administered without trials that too in case of children.”

Tia Gupta, a minor, had filed a PIL seeking immediate vaccination for minors between 12 and 17 years of age.&nbsp;

Also read |&nbsp;<a href="https://www.wionews.com/india-news/indian-govt-issues-guidelines-on-covid-19-in-children-says-remdesivir-not-recommended-390531">Indian govt issues guidelines on COVID-19 in children, says Remdesivir not recommended</a>

Based on this plea, an affidavit was submitted by the Centre which said that a government policy will be developed and children will be vaccinated once experts approve.

The Centre notified the High Court that clinical trials for COVID-19 vaccines for children under 18 years of age are in progress and nearing completion.

Kailash Vasudev, appearing for the petitioner, argued that a specific timeline should be established for the completion of vaccine trials for children.

In response to which court officials warned that the case would be dismissed if the petitioner made such submissions. They added&nbsp;a timeline for the research was not possible.

Also read |&nbsp;<a href="https://www.wionews.com/world/astrazeneca-vaccine-to-be-tested-on-children-to-test-efficacy-363946">AstraZeneca vaccine to be tested on children to test efficacy</a>

The Centre informed the Delhi High Court that Zydus Cadila's COVID-19 vaccine may be available soon for children in the 12 to 18 year age group.

They added that while the trial of Zydus Cadila for children between the ages of 12 and 18 has been concluded, it is still subject to statutory approvals.

Earlier this month, the Ahmedabad-based pharmaceutical firm sought emergency use approval for ZyCoV-D. World's first Plasmid DNA vaccine, it is administered in three doses.

Also read |&nbsp;<a href="https://www.wionews.com/india-news/need-to-step-up-measures-for-well-being-protection-of-children-during-covid-19-second-wave-sc-judge-383754">Need to step up measures for well-being, protection of children during COVID-19 second wave: SC judge</a>

However, India's drug regulator, Drugs Controller General of India (DCGI), is yet to approve the emergency use authorisation.&nbsp;

In addition, the affidavit claimed that vaccination is of the highest priority at the Center and that all endeavours are being made to reach 100 per cent vaccination in the shortest time possible while taking into account the availability of vaccine doses.

(With inputs from Agencies)

While hearing a plea based case on Friday, a division bench of Chief Justice D N Patel and Justice Jyoti Singh observed, “It would be a disaster if vaccines are administered without trials that too in case of children.

While hearing a plea based case on Friday, a division bench of Chief Justice D N Patel and Justice Jyoti Singh observed, “It would be a disaster if vaccines are administered without trials that too in case of children.” Tia Gupta, a minor, had filed a PIL seeking immediate vaccination for minors between 12 and 17 years of age. Also read | Indian govt issues guidelines on COVID-19 in children, says Remdesivir not recommended Based on this plea, an affidavit was submitted by the Centre which said that a government policy will be developed and children will be vaccinated once experts approve. The Centre notified the High Court that clinical trials for COVID-19 vaccines for children under 18 years of age are in progress and nearing completion. Kailash Vasudev, appearing for the petitioner, argued that a specific timeline should be established for the completion of vaccine trials for children. In response to which court officials warned that the case would be dismissed if the petitioner made such submissions. They added a timeline for the research was not possible. Also read | AstraZeneca vaccine to be tested on children to test efficacy The Centre informed the Delhi High Court that Zydus Cadila's COVID-19 vaccine may be available soon for children in the 12 to 18 year age group. They added that while the trial of Zydus Cadila for children between the ages of 12 and 18 has been concluded, it is still subject to statutory approvals. Earlier this month, the Ahmedabad-based pharmaceutical firm sought emergency use approval for ZyCoV-D. World's first Plasmid DNA vaccine, it is administered in three doses. Also read | Need to step up measures for well-being, protection of children during COVID-19 second wave: SC judge However, India's drug regulator, Drugs Controller General of India (DCGI), is yet to approve the emergency use authorisation. In addition, the affidavit claimed that vaccination is of the highest priority at the Center and that all endeavours are being made to reach 100 per cent vaccination in the shortest time possible while taking into account the availability of vaccine doses. (With inputs from Agencies)

Vaccinating children without clinical trials can be disastrous: Delhi HC

covid-vaccine-for-children

Covid Vaccine For Children, News on Covid Vaccine For Children, stories on Covid Vaccine For Children, articles on Covid Vaccine For Children, Covid Vaccine For Children stories at Wion, Covid Vaccine For Children news, Covid Vaccine For Children latest news

covid vaccine-for-children

India: Covaxin yet to get DCGI nod for kids

Vaccinating children without clinical trials can be disastrous: Delhi HC